Wall Street analysts upgraded Stryker Corp (NYSE: SYK) after its Q4 report beat expectations, with strong sales and earnings ...

Stryker is selling off its spine implant business—starting with a plan to spin off its U.S. operations before moving on to ...

Q4 2024 Earnings Call Transcript January 28, 2025 Stryker Corporation beats earnings expectations. Reported EPS is $4.01, expectations were $3.87. Operator: Welcome to the Fourth Quarter 2024 Stryker ...

Stryker (SYK) agreed to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC, a family-owned investment firm ...

The buyer, Viscogliosi Brothers, will call the company VB Spine. Stryker also reported operating results and offered its ...

Stryker Corp reported fourth-quarter earnings that beat Wall Street estimates, with earnings of $4.01 per share, ahead of analysts’ expectations of $3.87. Revenue rose to $6.4 billion, slightly ahead ...

Stryker ( ($SYK) ) has shared an update. On January 28, 2025, Stryker announced the retirement of Glenn S. Boehnlein from his role as Vice ...

Stryker's CFO Glenn Boehnlein is retiring, and Preston Wells will succeed him as vice president and CFO, according to a Jan. 28 news release.

Stryker beat Wall Street estimates for fourth-quarter profit and forecast 2025 earnings largely above expectations on Tuesday, fueled by strong demand for its medical and surgical devices.

Stryker (SYK) announced that Glenn Boehnlein will retire from his role as VP, CFO. Boehnlein’s decision follows a 22-year career at Stryker.

"We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an independent company," said Kevin A. Lobo, Chair and Chief Executive Officer, ...

Medical technology company Stryker plans to sell its U.S. spinal implants business to investment firm Viscogliosi Brothers ...